CRAIG A TOOMAN

CIK 1201050 · President and CEO · last filed 2025-01-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

38

Lifetime Open-Market Net

-$3.37M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SLN President and CEO $6.69 $0 1 2025-01-06
ARATANA THERAPEUTICS, INC. (PETX) Delisted President and CEO 0 -$498.5K 15 2019-07-18
Viskase Holdings, Inc. (ENZN) Delisted Exec VP Finance, CFO 160,480 -$2.87M 16 2010-06-22

Recent Filings · Page 2 of 4

38 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2015-11-10 ARATANA THERAPEUTICS, INC. (PETX) Delisted Sell (S) −3,620 -$27.2K EDGAR
2015-11-04 Disp (D) $0
2015-10-02 ARATANA THERAPEUTICS, INC. (PETX) Delisted Sell (S) −3,250 -$26.2K EDGAR
2015-02-02 ARATANA THERAPEUTICS, INC. (PETX) Delisted Grant (A) +22,300 $0 EDGAR
2014-12-12 Grant (A) $0
2014-10-03 ARATANA THERAPEUTICS, INC. (PETX) Delisted Grant (A) +10,000 $0 EDGAR
2014-01-14 ARATANA THERAPEUTICS, INC. (PETX) Delisted Grant (A) $0 EDGAR
2013-12-13 Grant (A) $0
2013-11-12 ARATANA THERAPEUTICS, INC. (PETX) Delisted Grant (A) +44,550 $0 EDGAR
2012-12-17 Grant (A) $0
Showing 1120 of 38
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.